Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
Showing 181–240 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
… allogeneic CAR T cells.References Casneuf T, et al. Effects of daratumumab on natural killer cells and impact on clinical outcomes in rela…
…g L, Shahidi J, Yver A, Krop I; DESTINY-Breast01 Investigators. Trastuzumab deruxtecan in previously treated HER2-positive breast cancer. N Engl J Med…
…ex vivo expanded allogeneic NK cells after lymphodepletion with fludarabine and cyclophosphamide. Canines were given subcutaneous recombina…
…nufacturing, treated with a standard preconditioning regimen of Cy/Flu, and receive IL-12 GEMys intravenously in a 3+3 dose escalation…
…ctivator, for 6 days. All patient tissues responded strongly to Staurosporine and variably to SEA. γδ T cells led to tumor killing in 2 out o…
…ted with defined cytokine combinations (IL-2, IL-15, IL-18, and IL-21). Cultures were maintained for 10–14 days without media exchang…
…II disease (93%). 55% (42/76) were treated with Ipilimumab plus Nivolumab (I/N), 41% (31/76) anti-PD1 monotherapy (PD1) and 4% (3/76) Niv…
…ls. Using scRNA-seq and TCR-seq data from patients treated with lifileucel,3 we confirmed that tumoricidal TIL express high levels of LTB,…
…oth metastatic and adjuvant cancer settings. DC-based vaccines (DC Vax) are capable of eliciting tumor-specific immune responses; howe…
…y in evaluating ADCC antibodies like Trastuzumab, Margetuximab, Rituximab and Blinatumomab. Collectively, the NCG-hIL2 and NCG-hIL15 mode…
…gulatory T cell phenotypes. In addition, CD8 T cells exposed to ethanol showed reduced capacity for IFN stimulation (via EliSPOT) and c…
…, Gravis G, et al. Randomized, double-blind, phase III trial of ipilimumab versus placebo in asymptomatic or minimally symptomatic patient…